Concepedia

Aziz Nazha

AN

70

Publications

4.5K

Citations

40

H-Index

2010

Active since

Affiliations

Cleveland Clinic(Current)

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Case Western Reserve University

Dana-Farber Cancer Institute

Aziz Nazha is an author at Cleveland Clinic specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2010–2023

70

Publications

70

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

Farhad Ravandi, Mona Lisa Alattar, Michael R. Grunwald et al. · Blood · 2013 · 373 citations · Full text

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

Detlef Haase, Kristen E. Stevenson, Donna Neuberg et al. · Leukemia · 2019 · 252 citations · Full text

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

Mikkael A. Sekeres, Megan Othus, Alan F. List et al. · Journal of Clinical Oncology · 2017 · 236 citations · Full text

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer

Remco J. Molenaar, Surbhi Sidana, Tomas Radivoyevitch et al. · Journal of Clinical Oncology · 2017 · 154 citations · Full text

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

Aziz Nazha, Mayur Narkhede, Tomas Radivoyevitch et al. · Leukemia · 2016 · 150 citations

, , +10

Rows per page

1–5 of 70